These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 26516724

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older.
    Komase Y, Asako A, Kobayashi A, Sharma R.
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1365-75. PubMed ID: 25525354
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials.
    Riley JH, Tabberer M, Richard N, Donald A, Church A, Harris SS.
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1873-80. PubMed ID: 27578968
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).
    Hamilton M, Leggett R, Pang C, Charles S, Gillett B, Prime D.
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):498-506. PubMed ID: 26372465
    [Abstract] [Full Text] [Related]

  • 13. First-time handling of different inhalers by chronic obstructive lung disease patients.
    Harb HS, Laz NI, Rabea H, Abdelrahim MEA.
    Exp Lung Res; 2020 Sep; 46(7):258-269. PubMed ID: 32614625
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone Furoate.
    Mehta R, Moore A, Riddell K, Joshi S, Chan R.
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):332-338. PubMed ID: 28463040
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of dry powder inhalers with a focus on ease of use and user preference in inhaler-naïve individuals.
    von Schantz S, Katajavuori N, Antikainen O, Juppo A.
    Int J Pharm; 2016 Jul 25; 509(1-2):50-58. PubMed ID: 27208655
    [Abstract] [Full Text] [Related]

  • 20. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler.
    Serra-Batlles J, Plaza V, Badiola C, Morejón E, Inhalation Devices Study Group.
    J Aerosol Med; 2002 Jul 25; 15(1):59-64. PubMed ID: 12006146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.